TD Cowen analyst Yaron Werber maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $59.00.

If you have an extra $1,000 lying around, you may want to put it to use in high-yielding stocks. That includes high-yielders like Exxon Mobil (NYSE:XOM), AT&T (NYSE:T), and AGNC Investment ...

Wall Street analysts anticipate Netflix will report strong Q1 2025 earnings and say the company is positioned to withstand an ...

TD Cowen analyst Gary Taylor raised the firm’s price target on Agilon Health (AGL) to $6 from $3.50 and keeps a Hold rating on the shares. The ...

TD Cowen lowered its price target for NVIDIA (NVDA, Financials) to $140 from $175, sticking with a Buy rating even as the ...

TD Cowen’s target price would indicate a potential downside of 4.11% from the stock’s current price. Several other research analysts have also commented on the stock.

Microsoft has walked away from data center projects in the US and Europe to the tune of 2GW, said TD Cowen analysts. First ...

TD Cowen sees the drop as overdone, noting Gulfport’s attractive 2025 cash yield of 17% and a discounted EV/EBITDAX of 3.03x compared to peers at 5.2x. Execution remains strong, and TD view the ...

Microsoft has abandoned data center projects set to use 2 gigawatts of electricity in the U.S. and Europe in the last six ...

Microsoft Corp. has walked away from new data center projects in the US and Europe that would have amounted to a capacity of about 2 gigawatts of electricity, according to TD Cowen analysts ...

Fintel reports that on April 14, 2025, TD Cowen downgraded their outlook for Medpace Holdings (NasdaqGS:MEDP) from Buy to Hold. Analyst Price Forecast Suggests 15.86% Upside As of April 2, 2025, the ...